Methodology Study of Novel Outcome Measures to Assess Progression of ALS



Status:Active, not recruiting
Conditions:Neurology, Neurology, Neurology, ALS
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:16 - 85
Updated:8/10/2018
Start Date:January 6, 2016
End Date:August 2, 2019

Use our guide to learn which trials are right for you!

Methodology Study of Novel Electrophysiological, Physical, and Imaging Outcome Measures to Assess the Progression of Amyotrophic Lateral Sclerosis

The primary objectives of the study are to estimate and rank-order the longitudinal
standardized mean changes over 6 months and over 12 months, for a set of novel outcome
measures administered to participants with amyotrophic lateral sclerosis (ALS), in order to
identify measures that are more sensitive to disease progression than Amyotrophic Lateral
Sclerosis Functional Rating Scale-Revised (ALSFRS-R). The secondary objectives of this study
are: To evaluate the test-retest reproducibility of each outcome measure; To determine
correlations between 6 and 12-month changes in all exploratory measures with 18 and 24-month
changes in ALSFRS-R and survival; To assess correlations between/among the various measures;
To obtain biological samples in order to identify molecular correlates to the clinical
measures and to further characterize previously identified and novel molecular biomarkers of
disease progression for incorporation into future clinical studies.


Key Inclusion Criteria:

- A diagnosis of sporadic or familial ALS

- ALS onset within ≤5 years

- Must be 16 to 85 years of age, inclusive, for sites in the United States and 18 to 85
years of age, inclusive, for all sites outside of the United States

Key Exclusion Criteria:

- History of or positive test result at Screening for human immunodeficiency virus (HIV)

- History of or positive test result at Screening for hepatitis C virus (HCV) antibody
or hepatitis B virus (HBV)

- Possibility of neuromuscular weakness other than ALS

- Unspecified reasons that, in the opinion of the site Investigator, make the subject
unsuitable for enrollment or unlikely to be able to complete, at a minimum, the Month
6 Visit

NOTE: Other protocol defined Inclusion/ Exclusion criteria may apply
We found this trial at
9
sites
500 University Dr
Hershey, Pennsylvania 17033
(717) 531-6955
Penn State Milton S. Hershey Medical Center Penn State Milton S. Hershey Medical Center, Penn...
?
mi
from
Hershey, PA
Click here to add this to my saved trials
4202 E Fowler Ave
Tampa, Florida 33620
(813) 974-2011
University of South Florida The University of South Florida is a high-impact, global research university...
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Atlanta, Georgia 30322
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
1800 Orleans St.
Baltimore, Maryland 21287
410-955-5000
Johns Hopkins Hospital Patients are the focus of everything we do at The Johns Hopkins...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Charlestown, Massachusetts
?
mi
from
Charlestown, MA
Click here to add this to my saved trials
Leuven, 3001
?
mi
from
Leuven,
Click here to add this to my saved trials
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
?
mi
from
San Diego, CA
Click here to add this to my saved trials
45 Castro Street
San Francisco, California 94114
(415) 600-6000
California Pacific Medical Center California Pacific Medical Center is one of the largest private, not-for-profit,...
?
mi
from
San Francisco, CA
Click here to add this to my saved trials